Join to View Full Profile
110 Irving St NwWashington, DC 20010
Phone+1 202-877-6190
Fax+1 202-877-3820
Are you Dr. Seidman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Seidman, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland.
Education & Training
University of MarylandResidency, Pathology-Anatomic and Clinical, 1988 - 1990
MedStart Georgetown University HospitalInternship, Transitional Year, 1987 - 1988
State University of New York Downstate Medical Center College of MedicineClass of 1987
SUNY Upstate Medical UniversityClass of 1987
Certifications & Licensure
MD State Medical License 1990 - 2025
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 6 citationsPathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging.Marios A. Gavrielides, Brigitte M. Ronnett, Russell Vang, Stephanie Barak, Elsie Lee
Archives of Pathology & Laboratory Medicine. 2021-12-01 - 24 citationsFDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L. Osgood, Yutao Gong, Hui Zhang, Erik Bloomquist
Clinical Cancer Research. 2021-04-15 - 79 citationsFDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.Preeti Narayan, Tatiana M. Prowell, Jennifer J Gao, Laura L. Fernandes, Emily Li
Clinical Cancer Research. 2021-04-01
